Dr Reddy's Laboratories Ltd, an India-based multinational pharmaceutical company, has entered into a licensing agreement with US-based Ingenus Pharmaceuticals, LLC to market cyclophosphamide injection, which is used to treat cancer...
Ipsen announced that Iqirvo (elafibranor) 80 mg tablets have received accelerated approval from the US Food and Drug Administration (FDA) to treat primary biliary cholangitis (PBC) in adults who do not respond well to ursodeoxycholic acid (UDCA)...
Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent to Nexium 24 HR...
Akums Drugs & Pharmaceuticals Ltd declared the launch of Rabeprazole + Levosulpiride SR capsules. This new formulation, which was approved by the Drug Controller General of India (DCGI), aims to provide patients with better relief from disorders...
Essential Pharma, an international specialty pharmaceutical group dedicated to guaranteeing patients' long-term availability of low volume, clinically differentiated, niche pharmaceutical products across key therapeutic fields, declared that its...
Chugai Pharmaceutical Co, a drug manufacturer declared that the European Commission has sanctioned a Chugai originated anaplastic lymphoma kinase (ALK) inhibitor Alecensa monotherapy, as adjuvant treatment following growth resection for grown-up...
Akums Drugs & Pharmaceuticals Limited, known for its innovative approach to healthcare and pharmaceutical manufacturing, proudly concluded its series of Blood Donation Drives organized from June 5th to June 7th, 2024, across its widespread...
The U.S. Food and Drug Administration has granted advanced approval to the French drugmakers Ipsen and Genfit for their drug Iqirvo, which treats a chronic inflammatory liver disease called primary biliary cholangitis (PBC). PBC causes...
Hutchmed (China) Limited has started a phase I clinical trial of its menin inhibitor HMPL-506 in patients with haematological malignancies in China. The very first patient received their initial dose on May 31, 2024. This is a stage I...
CordenPharma, a worldwide CDMO pioneer in the production of drug substances (APIs) for complex modalities, LNPs containing xRNA/xDNA, and injectable medication items, and Certest, a Spanish organization focused on the improvement of new items with...
, CDSCO.jpg)
.jpg)